The Development of Molecular Biology of Osteoporosis
Open accessThe DOI matches its Crossref record; 164 of the 168 references it cites were found in a registry or an index.
Abstract
Osteoporosis is one of the major bone disorders that affects both women and men, and causes bone deterioration and bone strength. Bone remodeling maintains bone mass and mineral homeostasis through the balanced action of osteoblasts and osteoclasts, which are responsible for bone formation and bone resorption, respectively. The imbalance in bone remodeling is known to be the main cause of osteoporosis. The imbalance can be the result of the action of various molecules produced by one bone cell that acts on other bone cells and influence cell activity. The understanding of the effect of these molecules on bone can help identify new targets and therapeutics to prevent and treat bone disorders. In this article, we have focused on molecules that are produced by osteoblasts, osteocytes, and osteoclasts and their mechanism of action on these cells. We have also summarized the different pharmacological osteoporosis treatments that target different molecular aspects of these bone cells to minimize osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 The mechanism of action of osteoporosis therapeutics. The antiresorptive drugs such as bisphosphonate (BP), estrogen, anti-RANKLs (denosumab) and calcitonin; anabolic drugs such as PTH and anti-sclerostins (romosozumab) affecting different bone cells. + mean positive effect; − mean negative effect [10].](https://figures.cochat.ai/paper-figures/4698d96068934158895238e5275274e6/the-development-of-molecular-biology-of-osteoporosis-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Thus, it is thought that imbalances in these molecular and cellular processes alter bone homeostasis, driving the pathophysiology of osteoporosis [5,6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Self-citationNakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608 · cited 1×
“In these mice, mesenchymal cells could not deposit bone matrix, whereas cells in the periosteum failed to differentiate into osteoblasts [53].”
BackgroundDenosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Saag, K. G., Petersen, J., Brandi, M. L., Karaplis, A. C., Lorentzon, M., Thomas, T., Maddox, J., Fan, M., Meisner, P. D., & Grauer, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708322 · Cited by 1,544
Cellular and molecular mechanisms of bone remodeling
Raggatt, L. J., & Partridge, N. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.041087 · Cited by 1,402 · cited 1×
“Non-collagenous proteins, such as proteoglycans, alkaline phosphatase, small integrin-binding ligand (SIBLING) proteins, Gla-containing proteins (matrix Gla protein and osteocalcin), and lipids then form the remaining organic material and hydroxylapatite is deposited into new bone, replacing the resorbed bone [19].”
BackgroundEstrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts
Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.025 · Cited by 1,013
Khosla, S., Oursler, M. J., & Monroe, D. G. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.03.008 · Cited by 943
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 881
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Wnt signaling in development and tissue homeostasis
Steinhart, Z., & Angers, S. (2018) · Development · doi:10.1242/dev.146589 · Cited by 821
Regulation of bone development and extracellular matrix protein genes by RUNX2
Komori, T. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0832-8 · Cited by 804
Osteoclast differentiation by RANKL and OPG signaling pathways
Udagawa, N., Koide, M., Nakamura, M., Nakamichi, Y., Yamashita, T., Uehara, S., Kobayashi, Y., Furuya, Y., Yasuda, H., Fukuda, C., et al. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01162-6 · Cited by 708
Kenkre, J., & Bassett, J. (2018) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563218759371 · Cited by 693
Yeh, S., Tsai, M.-Y., Xu, Q., Mu, X.-M., Lardy, H., Huang, K.-E., Lin, H., Yeh, S.-D., Altuwaijri, S., Zhou, X., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212474399 · Cited by 668
Jiang, Y., Zhao, J. J., Mitlak, B. H., Wang, O., Genant, H. K., & Eriksen, E. F. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.11.1932 · Cited by 616
Johnston, C. B., & Dagar, M. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.06.004 · Cited by 615
The multiple functions and mechanisms of osteopontin
Icer, M. A., & Gezmen-Karadag, M. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.07.003 · Cited by 606
RANKL biology: bone metabolism, the immune system, and beyond
Ono, T., Hayashi, M., Sasaki, F., & Nakashima, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-019-0111-3 · Cited by 578
Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement
Siddiqui, J. A., & Partridge, N. C. (2016) · Physiology · doi:10.1152/physiol.00061.2014 · Cited by 534
Osteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
Developmental origin, functional maintenance and genetic rescue of osteoclasts
Jacome-Galarza, C. E., Percin, G. I., Muller, J. T., Mass, E., Lazarov, T., Eitler, J., Rauner, M., Yadav, V. K., Crozet, L., Bohm, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1105-7 · Cited by 475 · cited 1×
“These are multinucleated giant cells produced by fusion of hematopoietic stem cells-derived monocytic precursors in the presence of colony-stimulating factor 1 (CSF1) and RANKL [90].”
BackgroundThe mechanisms of estrogen regulation of bone resorption
Riggs, B. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11468 · Cited by 446
Energy Metabolism of the Osteoblast: Implications for Osteoporosis
Lee, W.-C., Guntur, A. R., Long, F., & Rosen, C. J. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00064 · Cited by 443 · cited 1×
“Dysfunction in osteoblast due to disorders of substrate availability such as diabetes mellitus, anorexia nervosa, and aging eventually leads to skeletal fragility and osteoporotic fractures [20].”
BackgroundOsteoporosis and the Ageing Skeleton
Aspray, T. J., & Hill, T. R. (2019) · Subcellular Biochemistry · doi:10.1007/978-981-13-3681-2_16 · Cited by 432
Estrogen and bone health in men and women
Cauley, J. A. (2015) · Steroids · doi:10.1016/j.steroids.2014.12.010 · Cited by 424
Cawthorn, W. P., Bree, A. J., Yao, Y., Du, B., Hemati, N., Martinez-Santibañez, G., & MacDougald, O. A. (2012) · Bone · doi:10.1016/j.bone.2011.08.010 · Cited by 415
The Regulation of Bone Metabolism and Disorders by Wnt Signaling
Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., Kayama, T., Saito, M., & Marumo, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225525 · Cited by 353
Bone Morphogenetic Protein-2 in Development and Bone Homeostasis
Halloran, D., Durbano, H. W., & Nohe, A. (2020) · Journal of Developmental Biology · doi:10.3390/jdb8030019 · Cited by 348
Bone Remodeling in Post-menopausal Osteoporosis
Lerner, U. H. (2006) · Journal of Dental Research · doi:10.1177/154405910608500703 · Cited by 347
Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene
Nishio, Y., Dong, Y., Paris, M., O'Keefe, R. J., Schwarz, E. M., & Drissi, H. (2006) · Gene · doi:10.1016/j.gene.2005.12.022 · Cited by 346
A road map for understanding molecular and genetic determinants of osteoporosis
Yang, T.-L., Shen, H., Liu, A., Dong, S.-S., Zhang, L., Deng, F.-Y., Zhao, Q., & Deng, H.-W. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0282-7 · Cited by 341
Osteocalcin: Skeletal and extra‐skeletal effects
Neve, A., Corrado, A., & Cantatore, F. P. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24278 · Cited by 335
Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts.
Pratap, J., Galindo, M. A., Zaidi, S. K., Vradii, D., Bhat, B. M., Robinson, J. A., Choi, J. Y., Komori, T., Stein, J. L., Lian, J. B., et al. (2003) · PubMed · Cited by 335
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & Canalis, E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 331
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation
Lotinun, S., Kiviranta, R., Matsubara, T., Alzate, J. A., Neff, L., Lüth, A., Koskivirta, I., Kleuser, B., Vacher, J., Vuorio, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64840 · Cited by 328
Suppressive function of androgen receptor in bone resorption
Kawano, H., Sato, T., Yamada, T., Matsumoto, T., Sekine, K., Watanabe, T., Nakamura, T., Fukuda, T., Yoshimura, K., Yoshizawa, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533500100 · Cited by 317
Osteopontin in Bone Metabolism and Bone Diseases
Si, J., Wang, C., Zhang, D., Wang, B., Hou, W., & Zhou, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.919159 · Cited by 301
Wnt signaling and cellular metabolism in osteoblasts
Karner, C. M., & Long, F. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2425-5 · Cited by 295
The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro
Spatz, J. M., Wein, M. N., Gooi, J. H., Qu, Y., Garr, J. L., Liu, S., Barry, K. J., Uda, Y., Lai, F., Dedic, C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628313 · Cited by 290
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
Noh, J.-Y., Yang, Y., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207623 · Cited by 287
Osteoclasts Provide Coupling Signals to Osteoblast Lineage Cells Through Multiple Mechanisms
Sims, N. A., & Martin, T. J. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034425 · Cited by 286
Tsao, Y.-T., Huang, Y.-J., Wu, H.-H., Liu, Y.-A., Liu, Y.-S., & Lee, O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010159 · Cited by 265
The Development of Functional Non-Viral Vectors for Gene Delivery
Patil, S., Gao, Y.-G., Lin, X., Li, Y., Dang, K., Tian, Y., Zhang, W.-J., Jiang, S.-F., Qadir, A., & Qian, A.-R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215491 · Cited by 263
Self-citationEstrogen therapy for osteoporosis in the modern era
Levin, V. A., Jiang, X., & Kagan, R. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4414-z · Cited by 258
Akt Induces Osteoclast Differentiation through Regulating the GSK3β/NFATc1 Signaling Cascade
Moon, J. B., Kim, J. H., Kim, K., Youn, B. U., Ko, A., Lee, S. Y., & Kim, N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101254 · Cited by 252
Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells
Streicher, C., Heyny, A., Andrukhova, O., Haigl, B., Slavic, S., Schüler, C., Kollmann, K., Kantner, I., Sexl, V., Kleiter, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06614-0 · Cited by 251
Galindo, M., Pratap, J., Young, D. W., Hovhannisyan, H., Im, H.-J., Choi, J.-Y., Lian, J. B., Stein, J. L., Stein, G. S., & van Wijnen, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413665200 · Cited by 241
Bone morphogenetic protein receptor signal transduction in human disease
Gomez‐Puerto, M. C., Iyengar, P. V., García de Vinuesa, A., ten Dijke, P., & Sanchez‐Duffhues, G. (2019) · The Journal of Pathology · doi:10.1002/path.5170 · Cited by 235
Selective estrogen receptor modulators: tissue specificity and clinical utility
Arnott, J., Martinkovich, S., Planey, S. L., & Shah, D. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s66690 · Cited by 234
Role of osteopontin in bone remodeling and orthodontic tooth movement: a review
Singh, A., Gill, G., Kaur, H., Amhmed, M., & Jakhu, H. (2018) · Progress in Orthodontics · doi:10.1186/s40510-018-0216-2 · Cited by 226
Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development
Li, H., Xiao, Z., Quarles, L. D., & Li, W. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200330142432 · Cited by 226
Pharmacology of bisphosphonates
Cremers, S., Drake, M. T., Ebetino, F. H., Bilezikian, J. P., & Russell, R. G. G. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13867 · Cited by 223
Cathepsin K: The Action in and Beyond Bone
Dai, R., Wu, Z., Chu, H. Y., Lu, J., Lyu, A., Liu, J., & Zhang, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00433 · Cited by 215
Roles of Runx2 in Skeletal Development
Komori, T. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-3233-2_6 · Cited by 209
Positive Regulation of Adult Bone Formation by Osteoblast-Specific Transcription Factor Osterix
Baek, W.-Y., Lee, M.-A., Jung, J. W., Kim, S.-Y., Akiyama, H., de Crombrugghe, B., & Kim, J.-E. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081248 · Cited by 193
Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
Nakamura, M., Udagawa, N., Matsuura, S., Mogi, M., Nakamura, H., Horiuchi, H., Saito, N., Hiraoka, B. Y., Kobayashi, Y., Takaoka, K., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0717 · Cited by 191
Metabolic reprogramming in osteoclasts
Park-Min, K.-H. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00757-0 · Cited by 191
Uda, Y., Azab, E., Sun, N., Shi, C., & Pajevic, P. D. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0373-0 · Cited by 190
Kawane, T., Qin, X., Jiang, Q., Miyazaki, T., Komori, H., Yoshida, C. A., Matsuura-Kawata, V. K. D. S., Sakane, C., Matsuo, Y., Nagai, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31853-0 · Cited by 189
Selective Estrogen receptor modulators
An, K.-C. (2016) · Asian Spine Journal · doi:10.4184/asj.2016.10.4.787 · Cited by 185
Osteoclastogenesis, Bone Resorption, and Osteoclast-Based Therapeutics
Zaidi, M., Blair, H. C., Moonga, B. S., Abe, E., & Huang, C. L.-H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.4.599 · Cited by 180
Strontium ranelate for preventing and treating postmenopausal osteoporosis
O'Donnell, S., Cranney, A., Wells, G., Adachi, J., & Reginster, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005326.pub3 · Cited by 179
Sapir-Koren, R., & Livshits, G. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2808-0 · Cited by 176
Physiology of Parathyroid Hormone
Goltzman, D. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.07.003 · Cited by 176
Denosumab: A review in postmenopausal osteoporosis
Deeks, E. D. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0525-7 · Cited by 169
McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H., Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30346-8 · Cited by 169
New horizons in treatment of osteoporosis
Tabatabaei-Malazy, O., Salari, P., Khashayar, P., & Larijani, B. (2017) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-017-0167-z · Cited by 166
Foxo1, a Novel Regulator of Osteoblast Differentiation and Skeletogenesis
Teixeira, C. C., Liu, Y., Thant, L. M., Pang, J., Palmer, G. D., & Alikhani, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079962 · Cited by 163
Hinoi, E., Fujimori, S., Wang, L., Hojo, H., Uno, K., & Yoneda, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600603200 · Cited by 161
Role of Cbfa1 in osteoblast differentiation and function
Karsenty, G. (2000) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0188 · Cited by 160
Ovarian Aging and Osteoporosis
Li, L., & Wang, Z. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1117-8_13 · Cited by 151
Regulation of Runx2 by post-translational modifications in osteoblast differentiation
Gomathi, K., Akshaya, N., Srinaath, N., Moorthi, A., & Selvamurugan, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117389 · Cited by 149
Sclerostin expression and functions beyond the osteocyte
Weivoda, M. M., Youssef, S. J., & Oursler, M. J. (2016) · Bone · doi:10.1016/j.bone.2016.11.024 · Cited by 148
Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells
Song, C., Yang, X., Lei, Y., Zhang, Z., Smith, W., Yan, J., & Kong, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27852 · Cited by 147
Xiong, J., Cawley, K., Piemontese, M., Fujiwara, Y., Zhao, H., Goellner, J. J., & O’Brien, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-05244-y · Cited by 144
Bone morphogenetic proteins in fracture repair
Dumić-Čule, I., Perić, M., Kucko, L., Grgurević, L., Pecina, M. M., & Vukičević, S. (2018) · International Orthopaedics · doi:10.1007/s00264-018-4153-y · Cited by 144
Female Mice Lacking Estrogen Receptor-Alpha in Osteoblasts Have Compromised Bone Mass and Strength
Melville, K. M., Kelly, N. H., Khan, S. A., Schimenti, J. C., Ross, F. P., Main, R. P., & van der Meulen, M. C. H. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2082 · Cited by 143
Kopf, J., Petersen, A., Duda, G. N., & Knaus, P. I. (2012) · BMC Biology · doi:10.1186/1741-7007-10-37 · Cited by 143
BMP‐2 Signaling and Mechanotransduction Synergize to Drive Osteogenic Differentiation via YAP/TAZ
Wei, Q., Holle, A. W., Li, J., Posa, F., Biagioni, F., Croci, O., Benk, A. S., Young, J. L., Noureddine, F., Deng, J., et al. (2020) · Advanced Science · doi:10.1002/advs.201902931 · Cited by 143
Chen, H.-L., Demiralp, B., Schneider, A., Koh, A. J., Silve, C., Wang, C.-Y., & McCauley, L. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108913200 · Cited by 142
Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice
Windahl, S. H., Börjesson, A. E., Farman, H. H., Engdahl, C., Movérare-Skrtic, S., Sjögren, K., Lagerquist, M. K., Kindblom, J. M., Koskela, A., Tuukkanen, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220811110 · Cited by 136
Wu, M., Chen, W., Lü, Y., Zhu, G., Hao, L., & Li, Y. (2017) · Nature Communications · doi:10.1038/ncomms13700 · Cited by 136
Synaptotagmin VII Regulates Bone Remodeling by Modulating Osteoclast and Osteoblast Secretion
Zhao, H., Ito, Y., Chappel, J. C., Andrews, N. W., Teitelbaum, S. L., & Ross, F. P. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.03.022 · Cited by 133
Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review
Ukon, Y., Makino, T., Kodama, J., Tsukazaki, H., Tateiwa, D., Yoshikawa, H., & Kaito, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102557 · Cited by 122
Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice
Kondoh, S., Inoue, K., Igarashi, K., Sugizaki, H., Shirode-Fukuda, Y., Inoue, E., Yu, T., Takeuchi, J. K., Kanno, J., Bonewald, L. F., et al. (2014) · Bone · doi:10.1016/j.bone.2013.12.005 · Cited by 119
Pharmacological treatment of osteoporosis in the oldest old
Vandenbroucke, A.-M., Luyten, F., Flamaing, J., & Gielen, E. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s131023 · Cited by 118
Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)
Rollason, V., Laverrière, A., MacDonald, L. C., Walsh, T., Tramèr, M. R., & Vogt-Ferrier, N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008455.pub2 · Cited by 116
Sinnesael, M., Claessens, F., Laurent, M., Dubois, V., Boonen, S., Deboel, L., & Vanderschueren, D. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1713 · Cited by 114
The Roles of FoxO Transcription Factors in Regulation of Bone Cells Function
Ma, X., Su, P., Yin, C., Lin, X., Wang, X., Gao, Y., Patil, S., War, A. R., Qadir, A. S., Tian, Y. E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030692 · Cited by 114
Self-citationComparison of non-invasive assessments of strength of the proximal femur
Jóhannesdóttir, F., Thrall, E., Muller, J. A., Keaveny, T. M., Kopperdahl, D. L., & Bouxsein, M. (2017) · Bone · doi:10.1016/j.bone.2017.07.023 · Cited by 113
OPG Production Matters Where It Happened
Tsukasaki, M., Asano, T., Muro, R., Huynh, N. C., Komatsu, N., Okamoto, K., Nakano, K., Okamura, T., Nitta, T., & Takayanagi, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108124 · Cited by 111
RANK/RANKL/OPG role in distraction osteogenesis
Pérez‐Sayáns, M., Martín, J. M. S., Barros, F., Rey, J. M. G., & García, A. G. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.10.042 · Cited by 104
Management of Osteoporosis in Chronic Kidney Disease
Nitta, K., Yajima, A., & Tsuchiya, K. (2017) · Internal Medicine · doi:10.2169/internalmedicine.8618-16 · Cited by 103
Sclerostin: from bench to bedside
Tanaka, S., & Matsumoto, T. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01176-0 · Cited by 103
Serum Osteocalcin as a Diagnostic Biomarker for Primary Osteoporosis in Women
Singh, S. K. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/14857.6318 · Cited by 102
Targeting WNT signaling in the treatment of osteoporosis
Baron, R., & Gori, F. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.04.011 · Cited by 101
Fujiwara, Y., Piemontese, M., Liu, Y., Thostenson, J. D., Xiong, J., & O'Brien, C. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.742452 · Cited by 99
Individualizing osteoporosis therapy
Silverman, S. L., & Christiansen, C. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1775-y · Cited by 96
Cbfb Regulates Bone Development by Stabilizing Runx Family Proteins
Qin, X., Jiang, Q., Matsuo, Y., Kawane, T., Komori, H., Moriishi, T., Taniuchi, I., Ito, K., Kawai, Y., Rokutanda, S., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2379 · Cited by 94
Ucer, S., Iyer, S. V., Bartell, S. M., Martín-Millán, M., Han, L., Kim, H., Weinstein, R. S., Jilka, R. L., O’Brien, C. A., Almeida, M., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2485 · Cited by 92
SP7 Inhibits Osteoblast Differentiation at a Late Stage in Mice
Yoshida, C. A., Komori, H., Maruyama, Z., Miyazaki, T., Kawasaki, K., Furuichi, T., Fukuyama, R., Mori, M., Yamana, K., Nakamura, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032364 · Cited by 92
Baek, W., Crombrugghe, B. D., & Kim, J. (2009) · Bone · doi:10.1016/j.bone.2009.12.007 · Cited by 92
FOXO1 modulates osteoblast differentiation
Siqueira, M. F., Flowers, S., Bhattacharya, R., Faibish, D., Behl, Y., Kotton, D. N., Gerstenfeld, L., Moran, E., & Graves, D. T. (2011) · Bone · doi:10.1016/j.bone.2011.01.019 · Cited by 88
Integrins in Osteocyte Biology and Mechanotransduction
Geoghegan, I. P., Hoey, D. A., & McNamara, L. M. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00520-2 · Cited by 88
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Yang, S., Xu, H., Yu, S., Cao, H., Fan, J., Ge, C., Fransceschi, R. T., Dong, H. H., & Xiao, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.197905 · Cited by 82
Osteoporosis and the Potential of Cell-Based Therapeutic Strategies
Macías, I., Alcorta-Sevillano, N., Rodríguez, C. I., & Infante, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051653 · Cited by 82
Bronisz, A., Sharma, S. M., Hu, R., Godlewski, J., Tzivion, G., Mansky, K. C., & Ostrowski, M. C. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0470 · Cited by 79
The role of integrin αVβ3 in osteocyte mechanotransduction
Haugh, M. G., Vaughan, T. J., & McNamara, L. M. (2015) · Journal of the Mechanical Behavior of Biomedical Materials · doi:10.1016/j.jmbbm.2014.11.001 · Cited by 78
Cathepsin K Controls Cortical Bone Formation by Degrading Periostin
Bonnet, N., Brun, J., Rousseau, J.-C., Duong, L. T., & Ferrari, S. L. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3136 · Cited by 77
Osagie-Clouard, L., Sanghani‐Kerai, A., Coathup, M. J., Briggs, T. W. R., Bostrom, M. P., & Blunn, G. W. (2017) · Bone and Joint Research · doi:10.1302/2046-3758.61.bjr-2016-0085.r1 · Cited by 73
The Role of MicroRNAs in Bone Metabolism and Disease
Gao, Y., Patil, S., & Qian, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176081 · Cited by 72
Self-citationCabahug‐Zuckerman, P., Stout, R. F., Majeska, R. J., Thi, M. M., Spray, D. C., Weinbaum, S., & Schaffler, M. B. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23792 · Cited by 71
Osteoclasts secrete osteopontin into resorption lacunae during bone resorption
Luukkonen, J., Hilli, M., Nakamura, M., Ritamo, I., Valmu, L., Kauppinen, K., Tuukkanen, J., & Lehenkari, P. P. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01770-y · Cited by 71
Sharma (2018) · doi:10.1016/j.bone.2018.01.019 · Cited by 70
The Role of Nrf2 in the Response to Normal Tissue Radiation Injury
Cameron, B. D., Sekhar, K. R., Ofori, M., & Freeman, M. L. (2018) · Radiation Research · doi:10.1667/rr15059.1 · Cited by 69
New therapeutic targets for osteoporosis
Anagnostis, P. G., Gkekas, N. K., Potoupnis, M. E., Kenanidis, E. I., Tsiridis, E. E., & Goulis, D. G. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.11.010 · Cited by 67
Stone, J. A., McCrea, J. B., Witter, R., Zajic, S., & Stoch, S. A. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13869 · Cited by 66
Pang, M., Rodríguez‐Gonzalez, M., Hernandez, M., Recinos, C. C., Seldeen, K. L., & Troen, B. R. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28504 · Cited by 66
Koide, M., Kobayashi, Y., Ninomiya, T., Nakamura, M., Yasuda, H., Arai, Y., Okahashi, N., Yoshinari, N., Takahashi, N., & Udagawa, N. (2013) · Endocrinology · doi:10.1210/en.2012-1928 · Cited by 65
Ge, Q., Ruan, C., Ma, Y., Tang, X., Wu, Q., Wang, J., Zhu, D., & Gao, P. (2017) · Scientific Reports · doi:10.1038/srep40253 · Cited by 64
MEF2C regulates osteoclastogenesis and pathologic bone resorption via c-FOS
Fujii, T., Murata, K., Mun, S. H., Bae, S., Lee, Y. J., Pannellini, T., Kang, K., Oliver, D., Park‐Min, K., & Ivashkiv, L. B. (2021) · Bone Research · doi:10.1038/s41413-020-00120-2 · Cited by 61
Segredo-Morales, E., García‐García, P., Reyes, R., Pérez‐Herrero, E., Delgado, A., & Évora, C. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.034 · Cited by 56
Romosozumab: A Review in Postmenopausal Osteoporosis
Paik, J., & Scott, L. J. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00793-8 · Cited by 56
PTEN regulation by the Akt/GSK-3β axis during RANKL signaling
Jang, H. D., Noh, J. Y., Shin, J. H., Lin, J., & Lee, S. Y. (2013) · Bone · doi:10.1016/j.bone.2013.02.005 · Cited by 53
Identification and characterization of glycation adducts on osteocalcin
Thomas, C. J., Cleland, T. P., Zhang, S., Gundberg, C. M., & Vashishth, D. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.02.011 · Cited by 53
The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases
Pathak, J. L., Bravenboer, N., & Klein-Nulend, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00405 · Cited by 53
Geoghegan, I. P., Hoey, D. A., & McNamara, L. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-41095-3 · Cited by 52
The androgen receptor has no direct antiresorptive actions in mouse osteoclasts
Sinnesael, M., Jardi, F., Deboel, L., Laurent, M. R., Dubois, V., Zajac, J. D., Davey, R. A., Carmeliet, G., Claessens, F., & Vanderschueren, D. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.030 · Cited by 50
Role of LncRNAs and CircRNAs in Bone Metabolism and Osteoporosis
Patil, S., Dang, K., Zhao, X., Gao, Y., & Qian, A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.584118 · Cited by 50
Self-citationOzaki, Y., Koide, M., Furuya, Y., Ninomiya, T., Yasuda, H., Nakamura, M., Kobayashi, Y., Takahashi, N., Yoshinari, N., & Udagawa, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184904 · Cited by 49
Lyles, K. W., & Bliuc, D. (2020) · Bone · doi:10.1016/j.bone.2020.115566 · Cited by 48
Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology
Matsuo, K., & Ray, N. (2004) · The Keio Journal of Medicine · doi:10.2302/kjm.53.78 · Cited by 47
Osteocalcin and its forms across the lifespan in adult men
Smith, C., Voisin, S. A. C., Saedi, A. A., Phu, S., Brennan‐Speranza, T. C., Parker, L., Eynon, N., Hiam, D., Yan, X., Scott, D. S., et al. (2019) · Bone · doi:10.1016/j.bone.2019.115085 · Cited by 43
Identification of a Role for the ARHGEF3 Gene in Postmenopausal Osteoporosis
Mullin, B. H., Prince, R. L., Dick, I. M., Hart, D. J., Spector, T. D., Dudbridge, F., & Wilson, S. G. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.04.016 · Cited by 41
Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis
Zhao, X., Patil, S., Xu, F., Lin, X., & Qian, A. (2021) · Biomolecules · doi:10.3390/biom11050747 · Cited by 41
Self-citationCarey, H. A., Hildreth, B. E., Geisler, J. A., Nickel, M. C., Cabrera, J., Ghosh, S., Jiang, Y., Yan, J., Lee, J., Makam, S., et al. (2018) · Bone Research · doi:10.1038/s41413-018-0011-1 · Cited by 40
Izawa, N., Kurotaki, D., Nomura, S., Fujita, T., Omata, Y., Yasui, T., Hirose, J., Matsumoto, T., Saito, T., Kadono, Y., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3689 · Cited by 40
The Role of FoxOs in Bone Health and Disease
Kim, H., Iyer, S. V., Ring, R., & Almeida, M. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.004 · Cited by 39
Nicks, K. M., Fujita, K., Fraser, D., McGregor, U., Drake, M. T., McGee-Lawrence, M. E., Westendorf, J. J., Monroe, D. G., & Khosla, S. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2723 · Cited by 38
Iyer, S. V., Han, L., Ambrogini, E., Yavropoulou, M. P., Fowlkes, J. L., Manolagas, S. C., & Almeida, M. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2934 · Cited by 36
Increased fracture callus mineralization and strength in cathepsin K knockout mice
Gentile, M. A., Soung, D. Y., Horrell, C., Samadfam, R., Drissi, H., & Duong, L. T. (2014) · Bone · doi:10.1016/j.bone.2014.04.032 · Cited by 35
Osterix is Required for Sonic Hedgehog-Induced Osteoblastic MC3T3-E1 Cell Differentiation
Tian, Y., Xu, Y., Fu, Q., & Dong, Y. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9369-7 · Cited by 32
Involvement of PU.1 in NFATc1 promoter function in osteoclast development
Ishiyama, K., Yashiro, T., Nakano, N., Kasakura, K., Miura, R., Hara, M., Kawai, F., Maeda, K., Tamura, N., Okumura, K., et al. (2015) · Allergology International · doi:10.1016/j.alit.2015.01.006 · Cited by 31
A novel role for cathepsin K in periosteal osteoclast precursors during fracture repair
Walia, B., Lingenheld, E. G., Duong, L. T., Sanjay, A., & Drissi, H. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13629 · Cited by 31
Zhao, J., Wu, Z., Yu, Y., Wang, L., & Li, C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26548 · Cited by 29
Calcitonina como agente analgésico: revisão dos mecanismos de ação e das aplicações clínicas
Yazdani, J., Khorshidi, R., Ghavimi, M. A., Mortazavi, A., Hagh, E. J., & Ahmadpour, F. (2019) · Brazilian Journal of Anesthesiology · doi:10.1016/j.bjan.2019.08.004 · Cited by 28
Osterix regulates corticalization for longitudinal bone growth via integrin β3 expression
Moon, Y. J., Yun, C.-Y., Choi, H., Kim, J. R., Park, B., & Cho, E. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0119-9 · Cited by 27
Zhao, B., Xing, G., & Wang, Y. (2019) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-019-1512-3 · Cited by 27
Dynamics of the sealing zone in cultured osteoclasts
Batsir, S., Geiger, B., & Kam, Z. (2016) · Cytoskeleton · doi:10.1002/cm.21350 · Cited by 24
Cathepsin K Preferentially Solubilizes Matured Bone Matrix
Borel, O., Gineyts, É., Bertholon, C., & Garnero, P. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9604-7 · Cited by 23
Lin, X., Xiao, Y., Chen, Z., Ma, J., Qiu, W., Zhang, K., Xu, F., Dang, K., & Qian, A. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110494 · Cited by 21
Fulzele, K. S., Dedic, C., Lai, F., Bouxsein, M., Lotinun, S., Baron, R., & Pajevic, P. D. (2018) · Bone · doi:10.1016/j.bone.2018.09.021 · Cited by 20
Calcitonin as an analgesic agent: review of mechanisms of action and clinical applications
Yazdani, J., Khorshidi, R., Ghavimi, M. A., Mortazavi, A., Hagh, E. J., & Ahmadpour, F. (2019) · Brazilian Journal of Anesthesiology (English Edition) · doi:10.1016/j.bjane.2019.08.003 · Cited by 19
Azab, E., Chandler, K. B., Uda, Y., Sun, N., Hussein, A. I., Shuwaikan, R., Lu, V., Costello, C. E., McComb, M. E., & Pajevic, P. D. (2020) · The FASEB Journal · doi:10.1096/fj.202000366r · Cited by 16
Osterix plays a critical role in BMP4-induced promoter activity of connexin43
Han, Y., Cho, D. H., Chung, D. J., & Lee, K. Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.007 · Cited by 15
Induction of fibrillin-2 and periostin expression in Osterix-knockdown MC3T3-E1 cells
Lee, S.-J., Lee, E.-H., Park, S., & Kim, J. (2016) · Gene · doi:10.1016/j.gene.2016.10.018 · Cited by 14
Osteoclasts in Health and Disease.
Lerner, U. H. (2019) · PubMed · doi:10.17458/per.vol17.2019.l.osteoclastshealthdisease · Cited by 14
Zhou, Z.-H., Wang, N., Ding, C., Zhou, X., & Zhou, J. (2016) · PubMed · doi:10.13703/j.0255-2930.2016.07.008 · Cited by 7
Serum osteocalcin levels in postmenopausal osteoporotic women receiving alendronate
Soroush, M. G., Khabbazi, A., & Mahdavi, A. M. (2018) · Rheumatology Research · doi:10.22631/rr.2018.69997.1046 · Cited by 5
Anabolic action of teriparatide to osteoporotic patients
Hasegawa, T., Miyamoto, Y., Yamamoto, T., & Amizuka, N. (2019) · Folia Pharmacologica Japonica · doi:10.1254/fpj.153.16 · Cited by 1
Cited by
Current Status of the Diagnosis and Management of Osteoporosis
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169465 · Cited by 412
“However, bone remodeling is also regulated by other systemic regulators (parathyroid hormone (PTH), vitamin D, calcitonin or glucocorticoids) and local regulators such as cytokines, growth factors mainly transforming growth factor beta (TGF-β), the macrophage colony-stimulating factor (M-CSF), receptor activators of n…”
BackgroundPapadopoulou, S. K., Papadimitriou, K., Voulgaridou, G., Georgaki, E., Tsotidou, E., Zantidou, O., & Papandreou, D. (2021) · Nutrients · doi:10.3390/nu13124499 · Cited by 231
Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics
Adejuyigbe, B., Kallini, J., Chiou, D., & Kallini, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914583 · Cited by 148
Maeda, K., Yoshida, K., Nishizawa, T., Otani, K., Yamashita, Y., Okabe, H., Hadano, Y., Kayama, T., Kurosaka, D., & Saito, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052871 · Cited by 161
Structural and Metabolic Changes in Bone
Wawrzyniak, A., & Balawender, K. (2022) · Animals · doi:10.3390/ani12151946 · Cited by 194
Metadata
- Authors
- Gao, Y., Patil, S., & Jia, J.
- Affiliations
- Tangshan Normal University (CN)
- Northwestern Polytechnical University (CN)
- Corresponding author
- Gao, Yongguang
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-07-30
- Volume
- 22
- Issue
- 15
- Pages
- 8182
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8347149
- OpenAlex
- W3191096784
- Cited by
- 116
- References
- 168
- Citations by year
- 2026: 9 · 2025: 27 · 2024: 33 · 2023: 22 · 2022: 18 · 2021: 6
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Science Foundation of Hebei Province (2021105001)
- Key project for scientific research in colleges and universities of Hebei province (ZD2021408)
- Scientific Research Foundation of Tangshan normal university (2021A03)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- osteoporosis, bone remodeling, osteoblasts, osteoclasts, osteocytes, bone resorption, bone formation, bone mineral homeostasis, paracrine signaling, bone disease
- MeSH terms
- Calcium-Regulating Hormones and Agents, Animals, Humans, Osteoclasts, Osteoporosis, Bone Remodeling, Bone Density Conservation Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.